Clinical Trials

Clinical trials and studies about imaging technology can be found on this channel.

Telemedicine industry veterans launch new venture to support health care providers and address the radiologist shortage

Whole Breast Ultrafractionation Radiotherapy After Breast-conserving Surgery in Early Breast Cancer had No Severe Toxicities and Did Not Affect Patient-reported Outcome

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

February 22, 2024

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 Mid-Winter Conference drew global experts exchanging the latest innovations in diagnostic and molecular imaging, cancer therapies, clinical trials and theranostics, as well and the role of artificial intelligence (AI) in nuclear medicine during its Feb. 1-3, 2024 meeting in Orlando, FL.

News | SNMMI

Society of Nuclear Medicine and Molecular Imaging (SNMMI) Mid-Winter Conference Focuses on Theranostics, AI, Diagnostic Imaging Innovations and Clinical Trials

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

February 06, 2024

New research funded by the National Institute for Health and Care Research (NIHR) has led to the UK government approving the use of digital pathology to help speed up analysis of cancer screening samples

News | Digital Pathology

Digital Pathology Cleared for Use in Cancer Screening Programs

Jan. 26, 2024 — New research funded by the National Institute for Health and Care Research (NIHR) has led to the UK ...

January 26, 2024

Graphical abstract of an advanced architecture for accurate mammogram segmentation. More information at https://github.com/uefcancer/Deepdensity

News | Breast Imaging

New Deep Learning Challenge to Estimate Breast Density from Mammograms

December 11, 2023 — A new deep learning challenge has been launched by the UEF Cancer AI research team, led by senior ...

December 11, 2023

Licensing agreement between Philochem and Blue Earth Diagnostics, one of the Bracco family of companies, encompasses applications of OncoFAP for diagnostic and medical imaging

News | Radiopharmaceuticals and Tracers

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

December 06, 2023

From child-friendly head immobilization to more precise treatments, Children’s Hospital Los Angeles is at the forefront of advancing pediatric radiation care

News | Pediatric Imaging

4 Innovations Improving Pediatric Radiation Therapy

December 1, 2023 — The Radiation Oncology Program at Children’s Hospital Los Angeles is one of only a few in the country ...

December 01, 2023

Diffusion tensor imaging, an MRI technique, of the brain.

News | RSNA

RSNA 2023 Research Shows Soccer Heading Linked to Measurable Decline in Brain Function

November 28, 2023 — New research being presented this week at the annual meeting of the Radiological Society of North ...

November 28, 2023

Researchers evaluated thigh muscle volume in 134 participants and found a higher ratio of quadricep-hamstring volume was significantly associated with lower odds of total knee replacement

News | Magnetic Resonance Imaging (MRI)

Stronger Thigh Muscles May Prevent Knee Replacement Surgery

November 27, 2023 — Stronger quadriceps muscles, relative to the hamstrings, may lower the risk of total knee ...

November 27, 2023

Sporadic early-onset Alzheimer’s disease (EOAD) is rare and understudied

News | Magnetic Resonance Imaging (MRI)

Research Spotlight: Validating an MRI Biomarker for Early Onset Alzheimer’s Disease

October 19, 2023 — Alexandra Touroutoglou, PhD, and Bradford Dickerson, MD, neuroscientists in the department of ...

October 19, 2023

Radionetics initiates its first clinical program targeting MC2R

News | Radiation Oncology

Radionetics Oncology Announces Initiation of Phase 1 Radiopharmaceutical Program Against a Novel Target for Adrenocortical Carcinoma

October 17, 2023 — Radionetics Oncology, Inc., a clinical stage radiopharmaceutical company focused on the discovery and ...

October 17, 2023

The thymus is a gland located in the upper part of the chest. It has been long known that this small organ is important for immune defense development in children.

News | Computed Tomography (CT)

Immune System Ageing Can Be Revealed by CT Scan

October 17, 2023 — Thymus, a small and relatively unknown organ, may play a bigger role in the immune system of adults ...

October 17, 2023

Shorter treatment course found as effective as longer schedule for people with non-HPV-related locally advanced disease

News | Radiation Therapy

Accelerated Radiation Treatment Could Reduce Head and Neck Cancer Patient Burden in Low- and Middle-income Countries

October 2, 2023 — A type of head and neck cancer predominantly diagnosed in people who reside in low- and middle-income ...

October 02, 2023

Multi-center study achieves durable local control and cancer-specific survival after stereotactic radiation treatment

News | Stereotactic Body Radiation Therapy (SBRT)

High-dose Radiation Offers New Treatment Option for Older Patients with Inoperable Kidney Tumors

October 1, 2023 — Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted ...

October 01, 2023

Beilinson Hospital in Israel used Nanox.AI’s HealthCCSng solution to conduct study on routine chest CT scans to assess impact of AI-based coronary artery calcium (CAC) measurements

News | Computed Tomography (CT)

Nanox.AI’s HealthCCSng AI Solution Reveals ~60% of Patients in Study had Previously Undetected Risk of a Cardiovascular Event from Routine Chest CTs

September 29, 2023 —Nano-X Imaging, an innovative medical imaging technology company, today announced that HealthCCSng ...

September 29, 2023

Phase III trial finds fewer, higher doses cut treatment time while maintaining high rates of cure

News | Prostate Cancer

SBRT as Effective as Conventional Radiation for People with Intermediate Risk, Localized Prostate Cancer

September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer ...

September 29, 2023

Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy

News | Breast Imaging

Combination Radiation with Immunotherapy Shows Promise Against “Cold” Breast Cancer Tumors

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

September 27, 2023

Medical imaging artificial intelligence (AI) company Annalise.ai has announced that results from a pioneering clinical study, which examined whether its technology improves radiologists’ performance, have been published in the journal European Radiology.

News | Artificial Intelligence

Study Shows Annalise Deep Learning System Boosts Radiologist Accuracy and Speed for Head CTs

September 20, 2023 — Medical imaging artificial intelligence (AI) company Annalise.ai has announced that the results ...

September 20, 2023

Lunit's collaborative study supports AI as a viable alternative to one human reader in Europe’s double reading system - published in The Lancet Digital Health

News | Artificial Intelligence

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

September 11, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is ...

September 11, 2023

The clinical study of Positron’s Affinity PET-CT is designed to provide key information that evaluate the new system and its full capabilities with multiple radiopharmaceuticals and new coronary flow software applications that will enhance physician’s diagnostic analysis

News | PET-CT

Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device

September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...

September 08, 2023

STOPDAPT-3 trial presented in a Hot Line Session Saturday at ESC Congress 2023

News | Clinical Trials

Dual-antiplatelet Therapy Should Remain Standard Strategy After Stent Implantation

August 28, 2023 — Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not ...

August 28, 2023